Roger Strair

2.6k total citations
68 papers, 1.6k citations indexed

About

Roger Strair is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Roger Strair has authored 68 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 28 papers in Oncology and 16 papers in Hematology. Recurrent topics in Roger Strair's work include Chronic Lymphocytic Leukemia Research (8 papers), Acute Myeloid Leukemia Research (8 papers) and Virus-based gene therapy research (6 papers). Roger Strair is often cited by papers focused on Chronic Lymphocytic Leukemia Research (8 papers), Acute Myeloid Leukemia Research (8 papers) and Virus-based gene therapy research (6 papers). Roger Strair collaborates with scholars based in United States, Germany and United Kingdom. Roger Strair's co-authors include David A. Shafritz, Sing Hiem Yap, Dale Schaar, Daniel Medina, Ting Yi, Lauri Goodell, Arnold B. Rabson, Dirk F. Moore, Nashat Gabrail and John F. DiPersio and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Roger Strair

65 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roger Strair United States 21 783 422 325 257 209 68 1.6k
WN Hittelman United States 19 900 1.1× 597 1.4× 233 0.7× 224 0.9× 366 1.8× 39 1.9k
Arnaldo Arbini United States 25 905 1.2× 433 1.0× 159 0.5× 408 1.6× 396 1.9× 55 1.9k
Kiyoshi Okamoto Japan 15 611 0.8× 514 1.2× 200 0.6× 204 0.8× 267 1.3× 55 1.7k
Diponkar Banerjee Canada 23 381 0.5× 512 1.2× 199 0.6× 329 1.3× 180 0.9× 55 2.0k
Ernest Brahn United States 28 702 0.9× 542 1.3× 193 0.6× 250 1.0× 206 1.0× 64 2.5k
Ta‐Chih Liu Taiwan 24 698 0.9× 410 1.0× 156 0.5× 337 1.3× 356 1.7× 80 1.6k
Ken Ohmine Japan 21 605 0.8× 528 1.3× 110 0.3× 368 1.4× 124 0.6× 82 1.4k
Lise Willems France 16 1.2k 1.6× 314 0.7× 251 0.8× 557 2.2× 224 1.1× 48 1.9k
O. Müller France 17 741 0.9× 713 1.7× 109 0.3× 473 1.8× 138 0.7× 22 1.7k
Giovanni Abbadessa United States 24 732 0.9× 582 1.4× 264 0.8× 142 0.6× 170 0.8× 99 1.7k

Countries citing papers authored by Roger Strair

Since Specialization
Citations

This map shows the geographic impact of Roger Strair's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger Strair with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger Strair more than expected).

Fields of papers citing papers by Roger Strair

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger Strair. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger Strair. The network helps show where Roger Strair may publish in the future.

Co-authorship network of co-authors of Roger Strair

This figure shows the co-authorship network connecting the top 25 collaborators of Roger Strair. A scholar is included among the top collaborators of Roger Strair based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger Strair. Roger Strair is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Greenberg, Patricia, et al.. (2025). Prophylactic Vancomycin in the Primary Prevention of Clostridium difficile in Allogeneic Stem Cell Transplant. Transplant Infectious Disease. 27(3). e70025–e70025.
2.
Jonnalagadda, Subash C., et al.. (2025). Unlocking nature's potential: Soursop in the battle against resistant acute myeloid leukemia. Biochemistry and Biophysics Reports. 44. 102354–102354.
3.
David, Kevin A., et al.. (2017). The enteric toxicity of gluten enhances graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Medical Hypotheses. 104. 174–177. 1 indexed citations
4.
David, Kevin A., Dennis Cooper, & Roger Strair. (2017). Clinical Studies in Hematologic Microtransplantation. Current Hematologic Malignancy Reports. 12(1). 51–60. 10 indexed citations
5.
6.
Nichols, Gwen, Monica Reckner, Lyubomir T. Vassilev, et al.. (2011). Pharmacokinetics (PK) and pharmacodynamics (PD) of RG7112, an oral murine double minute 2 (MDM2) antagonist, in patients with leukemias and solid tumors.. Journal of Clinical Oncology. 29(15_suppl). 3039–3039. 6 indexed citations
7.
Yi, Ting, Daniel Medina, Roger Strair, & Dale Schaar. (2010). Differentiation-associated miR-22 represses Max expression and inhibits cell cycle progression. Biochemical and Biophysical Research Communications. 394(3). 606–611. 62 indexed citations
8.
Schaar, Dale, Daniel Medina, Dirk F. Moore, Roger Strair, & Ting Yi. (2009). miR-320 targets transferrin receptor 1 (CD71) and inhibits cell proliferation. Experimental Hematology. 37(2). 245–255. 116 indexed citations
9.
Ansell, Stephen M., Steven M. Horwitz, Andreas Engert, et al.. (2008). Increased doses of an anti-CD30 antibody, MDX-060, results in prolonged progression free survival in subjects with CD30 positive lymphoma.. Cancer Research. 68. 5525–5525. 2 indexed citations
10.
Medina, Daniel, Mecide Gharibo, Philip Savage, et al.. (2008). A Pilot study of allogeneic cellular therapy for patients with advanced hematologic malignancies. Leukemia Research. 32(12). 1842–1848. 12 indexed citations
11.
Ansell, Stephen M., Steven M. Horwitz, Andreas Engert, et al.. (2007). Phase I/II Study of an Anti-CD30 Monoclonal Antibody (MDX-060) in Hodgkin's Lymphoma and Anaplastic Large-Cell Lymphoma. Journal of Clinical Oncology. 25(19). 2764–2769. 193 indexed citations
12.
Schaar, Dale, Hao Liu, Shashi Sharma, et al.. (2005). 12-O-Tetradecanoylphorbol-13-acetate (TPA)-induced dual-specificity phosphatase expression and AML cell survival. Leukemia Research. 29(10). 1171–1179. 12 indexed citations
13.
Schaar, Dale, Lauri Goodell, Joseph Aisner, et al.. (2005). A phase I clinical trial of 12- O-tetradecanoylphorbol-13-acetate for patients with relapsed/refractory malignancies. Cancer Chemotherapy and Pharmacology. 57(6). 789–795. 42 indexed citations
14.
Medina, Daniel, et al.. (2005). Adenovirus infection and cytotoxicity of primary mantle cell lymphoma cells. Experimental Hematology. 33(11). 1337–1347. 4 indexed citations
15.
Strair, Roger, et al.. (2003). Heat insoluble cryoglobulin associated with gangrene in multiple myeloma. Journal of Clinical Apheresis. 18(4). 190–193. 6 indexed citations
16.
Zheng, Xi, Richard L. Chang, Katherine A. Kelly, et al.. (2001). Synergistic Effects of Clinically Achievable Concentrations of 12-O Tetradecanoylphorbol-13-acetate in Combination With all-trans Retinoic Acid, 1α,25-Dihydroxyvitamin D3, and Sodium. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 12(9). 419–427. 18 indexed citations
17.
Sandhaus, Linda M., et al.. (1996). Primary extramedullary leukemia of the prostate: Case report and review of the literature. American Journal of Hematology. 53(4). 267–271. 16 indexed citations
18.
Ravikumar, T.S., G Pizzorno, John C. Marsh, et al.. (1994). Percutaneous hepatic vein isolation and high-dose hepatic arterial infusion chemotherapy for unresectable liver tumors.. Journal of Clinical Oncology. 12(12). 2723–2736. 58 indexed citations
19.
Strair, Roger, et al.. (1993). Recombinant retroviral systems for the analysis of drug resistant HIV. Nucleic Acids Research. 21(20). 4836–4842. 11 indexed citations
20.
Glickman, Morton G., et al.. (1992). Percutaneous Isolated Liver Perfusion for Treatment of Hepatic Malignancy: Preliminary Report. Journal of Vascular and Interventional Radiology. 3(3). 453–458. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by WN Hittelman Breakdown of academic impact, for papers by Arnaldo Arbini Breakdown of academic impact, for papers by Kiyoshi Okamoto Breakdown of academic impact, for papers by Diponkar Banerjee Breakdown of academic impact, for papers by Ernest Brahn Breakdown of academic impact, for papers by Ta‐Chih Liu Breakdown of academic impact, for papers by Ken Ohmine Breakdown of academic impact, for papers by Lise Willems Breakdown of academic impact, for papers by O. Müller Breakdown of academic impact, for papers by Giovanni Abbadessa
Rankless by CCL
2026